Improved Cardiovascular Health Reduces Mortality Among Patients With Arthritis
Maintaining ideal cardiovascular health may lower the risk for all-cause mortality among patients with arthritis.
Related Articles
Myocardial Blood Flow Quantification Using Stress Cardiac Magnetic Resonance Improves Detection of Coronary Artery Disease:
AbstractBackgroundMyocardial blood flow (MBF) and myocardial perfusion reserve (MPR) using stress cardiovascular magnetic resonance (CMR) have been shown to identify epicardial coronary artery dise…
More beans, peas, lentils: A nutrition expert’s take on new guidelines
Americans are not eating well, Stanford Medicine’s Christopher Gardner says, but he is hopeful that encouraging patterns of eating — such as the Mediterranean diet…
T-Cell, NK-Cell Lymphoma Classification: Disease Heterogeneity a Persisting Issue | Blood Cancers Today
Diagnosis is challenging due to the high variety of origin cell types, clinical manifestations, genetics, and histology.
Oncology Brothers Live Event (ASCO GI 25)
Get tickets online for Oncology Brothers Live Event (ASCO GI 25) here.
Biodiversity Conservation and Forestry Programs Annual Report | Reports to Congress | U.S. Agency for International Development
To satisfy the requirements of Sections 118(f) and 119(h) of Part I of Public Law 87-195, the Foreign Assistance Act of 1961, as amended, the…
Venetoclax, Cladribine, Idarubicin, Cytarabine Regimen Evaluated in AML, High-Risk MDS | Docwire News
The combination in a phase II trial produced high complete response rates in patients with newly diagnosed AML.
What Is Ailing Nephrology? | Docwire News
Nephrology Times editorial board chair Dr. Ajay Singh discusses the reasons why medical students and residents are not choosing to pursue careers in nephrology.
Clonal Analysis Reveals Shared Splicing Neoantigens and Therapeutic Targets | Blood Cancers Today
Research shows that shared splicing neoantigens and key molecular pathways could inform future therapies for MDS and myelodysplasia-related AML.
Researcher Shares Insights on Patient-Reported Outcomes, Quality of Life in CLL12 Trial | Cancer Nursing Today
Ellinor Goergen, MD, of the University of Cologne in Germany, discusses her ASH 2024 presentation on quality-of-life outcomes in the phase III CLL12 trial.
